Literature DB >> 29650093

Dyslipidemia.

G B John Mancini, Robert A Hegele, Lawrence A Leiter.   

Abstract

Entities:  

Mesh：

Year:  2018        PMID： 29650093     DOI： 10.1016/j.jcjd.2017.10.019

Source DB:  PubMed          Journal:  Can J Diabetes        ISSN： 1499-2671            Impact factor:   4.190


× No keyword cloud information.
  10 in total

1.  Feasibility of identifying and describing the burden of early-onset metabolic syndrome in primary care electronic medical record data: a cross-sectional analysis.

Authors:  Jamie J Boisvenue; Carlo U Oliva; Donna P Manca; Jeffrey A Johnson; Roseanne O Yeung
Journal:  CMAJ Open       Date:  2020-11-24

2.  A Modern Approach to Dyslipidemia.

Authors:  Amanda J Berberich; Robert A Hegele
Journal:  Endocr Rev       Date:  2022-07-13       Impact factor: 25.261

3.  Barriers and Facilitators to Using Statins: A Qualitative Study With Patients and Family Physicians.

Authors:  Sonia Butalia; Rachelle C W Lee-Krueger; Kerry A McBrien; Alexander A C Leung; Todd J Anderson; Hude Quan; Christopher Naugler; Guanmin Chen; David J T Campbell
Journal:  CJC Open       Date:  2020-07-04

4.  Underuse of cardiorenal protective agents in high-risk diabetes patients in primary care: a cross-sectional study.

Authors:  Robin Hao; Tyler Myroniuk; Taylor McGuckin; Donna Manca; Denise Campbell-Scherer; Darren Lau; Roseanne O Yeung
Journal:  BMC Prim Care       Date:  2022-05-24

5.  Monitoring, treatment and control of blood glucose and lipids in Ontario First Nations people with diabetes.

Authors:  Michael E Green; Baiju R Shah; Morgan Slater; Shahriar Khan; Carmen R Jones; Jennifer D Walker
Journal:  CMAJ       Date:  2020-08-17       Impact factor: 8.262

Review 6.  Managing Cardiovascular Risk in Type 2 Diabetes: What Do the Cardiovascular Outcome Trials Mean for Australian Practice?

Authors:  Gary Deed; John J Atherton; Michael d'Emden; Roy Rasalam; Anita Sharma; Andrew Sindone
Journal:  Diabetes Ther       Date:  2019-07-10       Impact factor: 2.945

7.  The impact of environmental cadmium exposure on type 2 diabetes risk: a protocol for an overview of systematic reviews.

Authors:  Julia Hildebrand; Swarni Thakar; Tonya-Leah Watts; Laura Banfield; Lehana Thabane; Joseph Macri; Stephen Hill; M Constantine Samaan
Journal:  Syst Rev       Date:  2019-12-06

8.  Saturated fatty acids induce insulin resistance in podocytes through inhibition of IRS1 via activation of both IKKβ and mTORC1.

Authors:  Benoit Denhez; Marina Rousseau; Crysta Spino; David-Alexandre Dancosst; Marie-Ève Dumas; Andréanne Guay; Farah Lizotte; Pedro Geraldes
Journal:  Sci Rep       Date:  2020-12-10       Impact factor: 4.379

9.  Rhabdomyolysis due to warfarin and atorvastatin combination therapy in a patient with ischemic heart disease: (A drug interaction).

Authors:  Saeed Kargar Soliemanabad; Kimia Rasouli; Zakaria Zakariaei; Mostafa Soleymani; Parastoo Karimi Aliabadi
Journal:  Ann Med Surg (Lond)       Date:  2022-02-12

10.  Causal Association of Type 2 Diabetes Mellitus and Glycemic Traits With Cardiovascular Diseases and Lipid Traits: A Mendelian Randomization Study.

Authors:  Mingkai Huang; Loum-Davadi Laina-Nicaise; Lingfeng Zha; Tingting Tang; Xiang Cheng
Journal:  Front Endocrinol (Lausanne)       Date:  2022-04-22       Impact factor: 6.055
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.